In memoriam: Jerome Carl Landry, MD, MBA

0Comments

Winship Cancer Institute of Emory University, Emory University School of Medicine and Grady Memorial Hospital mourn the loss of Jerome Carl Landry, MD, MBA, professor of radiation oncology.

Landry was born and raised in Louisiana. After overcoming neurologic complications of polio at a young age, he graduated magna cum laude from Xavier University in New Orleans and then earned his medical degree from Harvard Medical School. He first joined Emory University in 1983 as a resident in internal medicine prior to returning to Harvard for his residency training in radiation therapy at Massachusetts General Hospital, where he served as chief resident in his final year. He also later received a Master of Business Administration degree from Kennesaw State University in Kennesaw, Georgia.

In 1987 he came back to Emory to join a small group of medical and surgical oncologists that formed what is now known as the Winship Cancer Institute. Additionally, he was tasked with developing radiation oncology services at Grady Memorial Hospital and served there as medical director until 2016.

An expert and pioneer in the field of radiation oncology and treatment of gastrointestinal tumors, Landry was the first to use and develop image-guided and advanced therapeutic techniques that now define modern radiation treatments and continue to improve patient outcomes. He published extensively on intensity modulated radiation therapy (IMRT) for gastrointestinal tumors and soft tissue sarcomas, providing on-site IMRT training in more than 40 radiation oncology centers in the US and abroad. His work has been highlighted at numerous medical and academic conferences.

“Dr. Landry’s ground-breaking research in developing new techniques in radiation therapy has helped to improve cancer care for patients with cancer in Georgia and beyond,” says Jeffrey Bradley, MD, James W. Keller Distinguished Professor in Radiation and interim chair for the Emory Department of Radiation Oncology.“His transformative work established Winship of Emory as a leader in IMRT.”

“Landry was a leader in the field of GI oncology and led national clinical trials,” says Suresh Ramalingam, MD, executive director of Winship Cancer Institute.“He leaves a long-lasting legacy in the field and at Winship.”

During his time at Winship, Landry won numerous awards and was consistently recognized by his peers as one of the best doctors in America by several publications, including Atlanta Magazine.

In remembering Landry, Joseph Shelton, MD, associate professor of radiation oncology and medical director of the Loughlin Radiation Oncology Center at Grady Memorial Hospital, says,“Jerome was a foundational figure in our department, a passionate advocate for patient care at Grady, and beyond his academic accomplishments, he was a genuinely kind person who provided joy to those who knew him. He was a valued mentor and friend to me throughout my career.”

After three decades of service, Landry left Emory in 2016 for health-related issues but remained an engaged and valuable resource to those at Emory. In 2018 an endowed professorship was established in his name and is currently held by David S. Yu, MD, PhD, the inaugural Jerome Landry, MD, Chair of Cancer Biology and associate professor of radiation oncology. Yu says of Landry: “He was a force in our department, mentoring and training countless faculty and students.”

Landry is survived by his long-time partner, Dwillete Johnson.

In lieu of flowers and to honor Landry’s passionate service to this institution, the family requests donations be made to Emory University to support the endowed professorship named in his honor and to host an annual invited lecture at Winship Cancer Institute on topics related to his passions: representation of racial minorities in medicine, oncologic and health care delivery in underserved populations, and evolving paradigms in radiation and cancer care. Contributions can be made to the Winship Cancer Institute of Emory University, Office of Gift Records, Emory University, 1762 Clifton Rd. NE, Suite 1400, Atlanta, GA 30322.

Landry was born and raised in Louisiana. After overcoming neurologic complications of polio at a young age, he graduated magna cum laude from Xavier University in New Orleans and then earned his medical degree from Harvard Medical School. He first joined Emory University in 1983 as a resident in internal medicine prior to returning to Harvard for his residency training in radiation therapy at Massachusetts General Hospital, where he served as chief resident in his final year. He also later received a Master of Business Administration degree from Kennesaw State University in Kennesaw, Georgia.

In 1987 he came back to Emory to join a small group of medical and surgical oncologists that formed what is now known as the Winship Cancer Institute. Additionally, he was tasked with developing radiation oncology services at Grady Memorial Hospital and served there as medical director until 2016.

An expert and pioneer in the field of radiation oncology and treatment of gastrointestinal tumors, Landry was the first to use and develop image-guided and advanced therapeutic techniques that now define modern radiation treatments and continue to improve patient outcomes. He published extensively on intensity modulated radiation therapy (IMRT) for gastrointestinal tumors and soft tissue sarcomas, providing on-site IMRT training in more than 40 radiation oncology centers in the US and abroad. His work has been highlighted at numerous medical and academic conferences.

“Dr. Landry’s ground-breaking research in developing new techniques in radiation therapy has helped to improve cancer care for patients with cancer in Georgia and beyond,” says Jeffrey Bradley, MD, James W. Keller Distinguished Professor in Radiation and interim chair for the Emory Department of Radiation Oncology.“His transformative work established Winship of Emory as a leader in IMRT.”

“Landry was a leader in the field of GI oncology and led national clinical trials,” says Suresh Ramalingam, MD, executive director of Winship Cancer Institute.“He leaves a long-lasting legacy in the field and at Winship.”

During his time at Winship, Landry won numerous awards and was consistently recognized by his peers as one of the best doctors in America by several publications, including Atlanta Magazine.

In remembering Landry, Joseph Shelton, MD, associate professor of radiation oncology and medical director of the Loughlin Radiation Oncology Center at Grady Memorial Hospital, says,“Jerome was a foundational figure in our department, a passionate advocate for patient care at Grady, and beyond his academic accomplishments, he was a genuinely kind person who provided joy to those who knew him. He was a valued mentor and friend to me throughout my career.”

After three decades of service, Landry left Emory in 2016 for health-related issues but remained an engaged and valuable resource to those at Emory. In 2018 an endowed professorship was established in his name and is currently held by David S. Yu, MD, PhD, the inaugural Jerome Landry, MD, Chair of Cancer Biology and associate professor of radiation oncology. Yu says of Landry: “He was a force in our department, mentoring and training countless faculty and students.”

Landry is survived by his long-time partner, Dwillete Johnson.

In lieu of flowers and to honor Landry’s passionate service to this institution, the family requests donations be made to Emory University to support the endowed professorship named in his honor and to host an annual invited lecture at Winship Cancer Institute on topics related to his passions: representation of racial minorities in medicine, oncologic and health care delivery in underserved populations, and evolving paradigms in radiation and cancer care. Contributions can be made to the Winship Cancer Institute of Emory University, Office of Gift Records, Emory University, 1762 Clifton Rd. NE, Suite 1400, Atlanta, GA 30322.

Original source can be found here.



Related

Andrea Backman, Ph.D. President - Strayer University-Georgia

Cost of education at Strayer University-Georgia stays the same for all students in 2022-23 school year

Tuition rates remained steady for the 2022-23 academic year at Strayer University-Georgia, according to the latest data, according to the latest disclosure from the National Center for Education Statistics.

Andi Lipstein Fristedt, CDC Deputy Director for Policy , Communications, and Legislative Affairs /Chief Stragedy Officer - cdc.gov

Cost increased for all students at Interactive College of Technology-Chamblee during 2022-23 school year

Tuition increased by 4.1% at the Interactive College of Technology-Chamblee for the 2022-23 academic year, according to the latest available data, according to the latest disclosure from the National Center for Education Statistics.

Leocadia I. Zak, President, Agnes Scott College - Agnes Scott College

Cost of attending Agnes Scott College increased for all students during 2022-23 school year

Tuition increased by 3.5% for the 2022-23 academic year at Agnes Scott College, according to the most recent report, according to the latest disclosure from the National Center for Education Statistics.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from DeKalb GA News.